Pfizer CEO says it will be able to deliver Seagen’s cancer therapy at a scale not seen before with $43 billion deal

Pfizer CEO Albert Bourla said it will deliver Seagen’s cancer therapy to the world at a scale that hasn’t been seen before with its $43 billion acquisition.